Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Incretins are gut derived hormones, released after the ingestion of food. Incretins are classified into glucagon-like peptide-1 (GLP-1) and gastric inhibitory peptide (GIP). Both the molecules are inactivated by enzyme Dipeptidyl Peptidase-4 (DPP-4).
Oral traditional anti-diabetic drugs, often fail to maintain the desired normal level of glucose, especially in the postprandial condition. This has resulted in a strong need for better therapeutics such as incretin based drugs. Incretin not only increases the secretion of insulin by acting on pancreatic beta cells, but also inhibits the release of glucagon by acting on the pancreatic alpha cells.
The report details the trend, potential and market size of Incretin-based Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Incretin-based Drugsmarket, defines the market attractiveness level of Incretin-based Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Incretin-based Drugs industry, describes the types of Incretin-based Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Incretin-based Drugs market and the development prospects and opportunities of Incretin-based Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Incretin-based Drugs market in Chapter 13.
By Player:
Novartis
Takeda Pharmaceutical Company
Sanofi
Eli Lilly and Company
GlaxoSmithKline
Johnson & Johnson
AstraZeneca
Boehringer Ingelheim
Merck & Co
By Type:
Glucagon-like Peptide-1 Receptor (GLP-1) Agonists
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors
By End-User:
Oral Drugs
Injectable Drugs
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Incretin-based Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Incretin-based Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Incretin-based Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Incretin-based Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Incretin-based Drugs Market Analysis and Outlook to 2022
-
7.1 Global Incretin-based Drugs Consumption (2017-2022)
-
7.2 United States Incretin-based Drugs Consumption (2017-2022)
-
7.3 Europe Incretin-based Drugs Consumption (2017-2022)
-
7.4 China Incretin-based Drugs Consumption (2017-2022)
-
7.5 Japan Incretin-based Drugs Consumption (2017-2022)
-
7.6 India Incretin-based Drugs Consumption (2017-2022)
-
7.7 South Korea Incretin-based Drugs Consumption (2017-2022)
8 Region and Country-wise Incretin-based Drugs Market Analysis and Outlook to 2028
-
8.1 Global Incretin-based Drugs Consumption Forecast (2022-2028)
-
8.2 United States Incretin-based Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Incretin-based Drugs Consumption Forecast (2022-2028)
-
8.4 China Incretin-based Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Incretin-based Drugs Consumption Forecast (2022-2028)
-
8.6 India Incretin-based Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Incretin-based Drugs Consumption Forecast (2022-2028)
9 Global Incretin-based Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Incretin-based Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Glucagon-like Peptide-1 Receptor (GLP-1) Agonists Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Incretin-based Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oral Drugs Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Injectable Drugs Consumption and Growth Rate (2017-2022)
10 Global Incretin-based Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Incretin-based Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Glucagon-like Peptide-1 Receptor (GLP-1) Agonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Incretin-based Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
11 Global Incretin-based Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Incretin-based Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Incretin-based Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Incretin-based Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Incretin-based Drugs Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Incretin-based Drugs Product and Service
-
14.2 Takeda Pharmaceutical Company
-
14.2.1 Takeda Pharmaceutical Company Company Details
-
14.2.2 Takeda Pharmaceutical Company Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Takeda Pharmaceutical Company Incretin-based Drugs Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi Incretin-based Drugs Product and Service
-
14.4 Eli Lilly and Company
-
14.4.1 Eli Lilly and Company Company Details
-
14.4.2 Eli Lilly and Company Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Eli Lilly and Company Incretin-based Drugs Product and Service
-
14.5 GlaxoSmithKline
-
14.5.1 GlaxoSmithKline Company Details
-
14.5.2 GlaxoSmithKline Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline Incretin-based Drugs Product and Service
-
14.6 Johnson & Johnson
-
14.6.1 Johnson & Johnson Company Details
-
14.6.2 Johnson & Johnson Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson & Johnson Incretin-based Drugs Product and Service
-
14.7 AstraZeneca
-
14.7.1 AstraZeneca Company Details
-
14.7.2 AstraZeneca Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AstraZeneca Incretin-based Drugs Product and Service
-
14.8 Boehringer Ingelheim
-
14.8.1 Boehringer Ingelheim Company Details
-
14.8.2 Boehringer Ingelheim Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Boehringer Ingelheim Incretin-based Drugs Product and Service
-
14.9 Merck & Co
-
14.9.1 Merck & Co Company Details
-
14.9.2 Merck & Co Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck & Co Incretin-based Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Incretin-based Drugs
-
Figure Incretin-based Drugs Picture
-
Table Global Incretin-based Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Incretin-based Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Incretin-based Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Incretin-based Drugs Consumption by Country (2017-2022)
-
Figure United States Incretin-based Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Incretin-based Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Incretin-based Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Incretin-based Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Incretin-based Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Incretin-based Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Incretin-based Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Incretin-based Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Incretin-based Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Incretin-based Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Incretin-based Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Incretin-based Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Incretin-based Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glucagon-like Peptide-1 Receptor (GLP-1) Agonists Consumption and Growth Rate (2017-2022)
-
Figure Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Glucagon-like Peptide-1 Receptor (GLP-1) Agonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Incretin-based Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Incretin-based Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Incretin-based Drugs Product and Service
-
Table Takeda Pharmaceutical Company (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Company Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Company Incretin-based Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Incretin-based Drugs Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Incretin-based Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Incretin-based Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Incretin-based Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Incretin-based Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim Incretin-based Drugs Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Incretin-based Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Incretin-based Drugs Product and Service
-
